Clinical Trial Update: Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The Interferon-Gamma Endotype (The EMBRACE Trial) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (EMBRACE) is evaluating emapalumab for potential benefit in sepsis driven by an interferon-gamma endotype; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Emapalumab (emapalumab)

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: Sepsis | Phase 2 | Status: ACTIVE_NOT_RECRUITING